Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,239 | -9,858 | -6,666 | -4,156 | -23,652 |
| Depreciation Amortization | 245 | 204 | 67 | 35 | 397 |
| Income taxes - deferred | -50 | N/A | N/A | N/A | N/A |
| Accounts receivable | 125 | 23 | -95 | -55 | 413 |
| Other Working Capital | 1,240 | 549 | -424 | 83 | 8,200 |
| Other Operating Activity | 1,893 | 1,269 | 1,020 | 571 | 759 |
| Operating Cash Flow | $-7,787 | $-7,813 | $-6,097 | $-3,523 | $-13,883 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 18 | 4 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 8,143 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 26 |
| Investing Cash Flow | $18 | $4 | $N/A | $N/A | $8,169 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,644 | 2,695 | 2,606 | N/A | N/A |
| Debt Issued | 879 | 831 | 681 | N/A | N/A |
| Common Stock Issued | 178 | N/A | N/A | N/A | 3,655 |
| Other Financing Activity | -34 | -30 | -15 | 16 | 68 |
| Financing Cash Flow | $3,666 | $3,495 | $3,272 | $16 | $3,723 |
| Beginning Cash Position | 4,292 | 4,375 | 4,231 | 4,388 | 6,408 |
| End Cash Position | 189 | 61 | 1,406 | 881 | 4,417 |
| Net Cash Flow | $-4,103 | $-4,314 | $-2,825 | $-3,507 | $-1,991 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,787 | -7,813 | -6,097 | -3,523 | -13,883 |
| Capital Expenditure | N/A | 4 | N/A | N/A | N/A |
| Free Cash Flow | -7,787 | -7,810 | -6,097 | -3,523 | -13,883 |